Amisulpride and Obs - a phase IV clinical study of FDA data

Summary:

Obs is reported as a side effect among people who take Amisulpride (amisulpride), especially for people who are female, 20-29 old, also take Gilenya, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Obs when taking Amisulpride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Amisulpride from the FDA, and is updated regularly.

What is Amisulpride?

Amisulpride has active ingredients of amisulpride. eHealthMe is studying from 6,389 Amisulpride users. Check the latest studies of Amisulpride.

What is Obs?

Obs is found to be associated with 36 drugs and 226 conditions by eHealthMe. Check the latest studies of Obs.

On Apr, 08, 2026

6,364 people reported to have side effects when taking Amisulpride.
Among them, 21 people (0.33%) have Obs.

Among these 21 people:

What is the gender of people who have Obs when taking Amisulpride? *

female: 100 %
male: 0.0 %

What is the age of people who have Obs when taking Amisulpride? *

What are other drugs people take besides Amisulpride? *

Gilenya: 21 people, 100.00%
Tysabri: 6 people, 28.57%
Copaxone: 6 people, 28.57%
Avonex: 6 people, 28.57%

What are other side effects people have besides Obs? *

Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain): 21 people, 100.00%
Headache (pain in head): 21 people, 100.00%
Blood Brain Barrier Defect (blood brain barrier defect-this bbb defect causes the bbb to break down in many pathological situations eg around brain tumours and when there is inflammation in the cns): 21 people, 100.00%
Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 21 people, 100.00%
Cerebral Artery Stenosis (hardening of brain blood vessels): 21 people, 100.00%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 21 people, 100.00%
Confusion: 21 people, 100.00%
Confusional State: 21 people, 100.00%
Csf Measles Antibody Positive: 21 people, 100.00%
Csf Protein Increased: 21 people, 100.00%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 21 people, 100.00%
Depression: 20 people, 95.24%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Amisulpride and have Obs?

- Check whether Obs is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amisulpride:

Amisulpride (6,389 reports)

Obs treatments and more:

Obs (298 reports)

Browse all side effects of Amisulpride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Obs:

Obs (36 drugs)

Browse all the conditions that are associated with Obs:

Obs (226 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amisulpride (the active ingredients of Amisulpride) and Amisulpride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.